Insmed (INSM) FCF Margin Growth (1y) (2019 - 2026)
Insmed (INSM) FCF Margin Growth (1y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Insmed |
19.79 Bn |
18.57 Bn |
258.54 Mn |
21,926.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
21,926.00 |
| Dec 31, 2025 |
9,400.00 |
| Sep 30, 2025 |
4,151.00 |
| Jun 30, 2025 |
-5,101.00 |
| Mar 31, 2025 |
-4,325.00 |
| Dec 31, 2024 |
-3,525.00 |
| Sep 30, 2024 |
-2,157.00 |
| Jun 30, 2024 |
2,171.00 |
| Mar 31, 2024 |
-2,040.00 |
| Dec 31, 2023 |
2,297.00 |
| Sep 30, 2023 |
-4,254.00 |
| Jun 30, 2023 |
-401.00 |
| Mar 31, 2023 |
-2,833.00 |
| Dec 31, 2022 |
-2,992.00 |
| Sep 30, 2022 |
3,104.00 |
| Jun 30, 2022 |
1,268.00 |
| Mar 31, 2022 |
12,071.00 |
| Dec 31, 2021 |
1,159.00 |
| Sep 30, 2021 |
-2,838.00 |
| Jun 30, 2021 |
-8,495.00 |
